1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
67EAF31BAB6E3FD14852571540054650C
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/incentive-compensation-in-pharma-sales-aligning-people-performance-and-pay?opendocument
18
19opendocument
2098.80.143.34
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Sales and Marketing » Sales Management » Managing Sales Force » Rewards and Recognition

Incentive Compensation in Pharma Sales: Aligning People, Performance and Pay

DB Image

ID: 4890


Features:

Metrics, Graphics, Summary Matrix


Pages/Slides: 44


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

Non-members: Click here to sign-up for a complimentary tour of
"Incentive Compensation in Pharma Sales: Aligning People, Performance and Pay"


Study Overview
An effective incentive compensation plan for sales people is crucial for motivating and maintaining a successful sales force. This 44-slide presentation focuses on how leading pharmaceutical and biotech company leaders such as Pfizer and GlaxoSmithKline structure and implement incentive programs. It is designed to assist other pharma and biotech executives in designing their own programs with the right mix of metrics, monetary and non-monetary rewards, fairness, timing and motivational power. It can also provide a framework and incentive areas to consider to those outside the pharma industry.

Key Topic Areas
· Monetary and Non-Monetary Rewards: Examples from Pfizer and GlaxoSmithKline
· Mentor Programs
· Flexible Work Schedules
· Incentive Pay for Specialist Physicians
· Uncapped Incentives
· Territory Optimization: Balancing Relationship Depth with Market Change
· Enhancing Perceptions of Fairness
· Quota Setting Process
· Product Weighting and Detail Order
· Portfolio Kicker for Reaching Quota on all Portfolio Products
· Incentives and Performance Metrics
· Promoting Teamwork

Sample Key Findings
· Companies are moving away from “entitlement” cultures including across-the-board pay increases to more individual, pay-for-performance merit pay raises.
· Higher level, more experienced reps hit their bonus targets at much higher rates than entry-level reps – showing the value of experience in performing above expectations.
· An increasing percentage of companies reset quotas more than annually to offset their inability to forecast market and sales performance with high degrees of accuracy.

Sample Metrics
· Bonus percentages above targets segmented by experience levels
· Percent of companies using prescription and sales data as quota-setting factors
· Percent of companies using multi-variable Incentives
· Percentage of performance targets reps must hit to receive a bonus
· Frequency of distributing rewards
· Percent of companies using teamwork in incentive pay
· Percent of incentive plans focusing on specialist physicians
· Percentage of companies with uncapped incentive plans

Methodology
This research was conducted on behalf of a client and studies mirrored sales organizations in nine pharma and biotech companies in 2000. Additional data was based on a 1999 survey by the Hay Group involving 75 pharma, biotech and oncology companies.


Industries Profiled:
Pharmaceutical; Biotech; Health Care


Companies Profiled:
Pfizer; Sanofi-aventis; Merck; Novartis; AstraZeneca; GlaxoSmithKline; Bristol-Myers Squibb; Pharmacia (now Pfizer); Janssen

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.